R2

ALS Biomarkers Are Entering the Approval Fight

GLP-1 drugs can reduce adolescent obesity. Who will pay for years of treatment?

Stroke Recovery Needs More Than Scans and Scores

Alzheimer’s Pill Has Finished the Trial. Evidence Has Not.

The Cyclospora Test Was Wrong. Public Trust Cannot Be

China Just Put a Bispecific ADC Into Esophageal Cancer

New York Had Cooling-Tower Rules. Legionnaires’ Still Broke Through.

The ovaries were never the whole story: PMOS linked to heart attacks and strokes in more than two million women

The Novo Nordisk Foundation is going global on cardiometabolic disease.
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
